PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 7911049

The third UCH High Dose Meeting.

R Chopra
View original source ↗Export metadata ↓

Abstract

The use of high-dose chemotherapy continues to increase in the treatment of a variety of haematological and non-haematological malignancies. At the same time, a greater understanding of haemopoiesis and its regulation has enabled the rapid clinical introduction of a variety of haemopoietic growth factors and peripheral blood stem cell support. Advances in immunology have led to a better understanding of the underlying mechanisms of graft-versus-host disease and the immunology associated with alloBMT. The aim of the UCH High Dose Meeting has been to critically review these advances in light of ongoing and future clinical trials. This report highlights some of the topics discussed.

Explore related subjects

Academic Medical CentersAdolescentAdultAntineoplastic AgentsBone Marrow TransplantationChildChild, PreschoolClinical Trials as TopicDose-Response Relationship, DrugGraft vs Host DiseaseHematopoietic Stem CellsHumansInfantLeukemiaLondonMiddle AgedRandomized Controlled Trials as TopicTransplantation, HomologousConference Proceedings

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R Chopra. 1994. The third UCH High Dose Meeting.. https://pubmed.ncbi.nlm.nih.gov/7911049/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1997

Managing the interface between medical schools, hospitals, and clinical research.

OBJECTIVE: To review how academic health centers are coping with the changing environment of health care delivery with special emphasis on the impact of the changing health care system on clinical research. DESIGN: In response to Health and Human Services Secretary Donna Shalala's 1995 mandated review of the National Institutes of Health (NIH) Warren Grant Magnuson Clinical Center, an NIH review team visited 30 health facilities and government-owned organizations throughout the country. The review team determined what strategies are used by academic health centers to survive and thrive in the changing health care marketplace. The findings have implications for the NIH Clinical Center as well as academic health centers. CONCLUSIONS: Management strategies in successful academic health centers include streamlined governance structures whereby small groups of highly empowered group leaders allow institutions to move quickly and decisively; an active strategic planning process; close integration of hospital and medical school management; heavy investment in information systems; and new structures for patient care delivery. Successful centers are initiating discussions with third-party payers and are implementing new initiatives, such as establishing their own managed care organizations, purchasing physician practices, or owning hospitals. Other approaches include establishing revenue-generating centers for clinical research and new relations with industry. Attention to the infrastructure required to support the training and conduct of clinical research is essential for the future vitality of medical schools.

Academic Medical Centers↗